Julio Enrique Serrano Noguès
Directeur/Membre du Conseil chez INBEST PRIME II INMUEBLES SOCIMI, S.A.
Profil
Julio Enrique Serrano Noguès is currently the Chief Executive Officer at Palbox Holding Sl and Director at Curapath & Expansion of Drug Delivery Capabilities & Services.
He is also a Director at Inbest Prime II Inmuebles SOCIMI SA and Inbest Prime III Inmuebles SOCIMI SA. Mr. Serrano Noguès completed his undergraduate degree at the University of Valencia.
Postes actifs de Julio Enrique Serrano Noguès
| Sociétés | Poste | Début |
|---|---|---|
| INBEST PRIME II INMUEBLES SOCIMI, S.A. | Directeur/Membre du Conseil | 13/05/2019 |
| INBEST PRIME III INMUEBLES SOCIMI, S.A. | Directeur/Membre du Conseil | 13/05/2019 |
| Palbox Holding Sl | Directeur Général | - |
Curapath & Expansion of Drug Delivery Capabilities & Services
 Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - |
Formation de Julio Enrique Serrano Noguès
| University of Valencia | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INBEST PRIME II INMUEBLES SOCIMI, S.A. | Finance |
| INBEST PRIME III INMUEBLES SOCIMI, S.A. | Finance |
| Entreprise privées | 2 |
|---|---|
| Palbox Holding Sl | |
Curapath & Expansion of Drug Delivery Capabilities & Services
Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Health Technology |
